Citation: R. Giess et al., CEREBRAL-ISCHEMIA CAUSED BY DESIGNER DRUGS IN A YOUNG MAN, Deutsche Medizinische Wochenschrift, 123(44), 1998, pp. 1308-1312
Authors:
RIECKMANN P
ALTENHOFEN B
RIEGEL A
KALLMANN B
FELGENHAUER K
Citation: P. Rieckmann et al., CORRELATION OF SOLUBLE ADHESION MOLECULES IN BLOOD AND CEREBROSPINAL-FLUID WITH MAGNETIC-RESONANCE-IMAGING ACTIVITY IN PATIENTS WITH MULTIPLE-SCLEROSIS, Multiple sclerosis, 4(3), 1998, pp. 178-182
Citation: N. Kruse et al., DETERMINATION OF A GENETIC DIMORPHISM USING ALLELE-SPECIFIC POLYMERASE-CHAIN-REACTION, European cytokine network, 9(3), 1998, pp. 88-88
Authors:
WEBER F
POLAK T
GUNTHER A
KUBUSCHOK B
JANOVSKAJA J
BITSCH A
POSER S
RIECKMANN P
Citation: F. Weber et al., SYNERGISTIC IMMUNOMODULATORY EFFECTS OF INTERFERON-BETA-1B AND THE PHOSPHODIESTERASE INHIBITOR PENTOXIFYLLINE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE-SCLEROSIS, Annals of neurology, 44(1), 1998, pp. 27-34
Authors:
BOGUMIL T
RIECKMANN P
KUBUSCHOK B
FELGENHAUER K
BRUCK W
Citation: T. Bogumil et al., SERUM LEVELS OF MACROPHAGE-DERIVED PROTEIN MRP-8 14 ARE ELEVATED IN ACTIVE MULTIPLE-SCLEROSIS/, Neuroscience letters, 247(2-3), 1998, pp. 195-197
Authors:
EBERS GC
RICE G
LESAUX J
PATY D
OGER J
LI DKB
BEALL S
DEVONSHIRE V
HASHIMOTO S
HOOGE J
KASTRUKOFF L
KRIEGER C
MEZEI M
SELAND P
VOROBEYCHI G
MORRISON W
NELSON J
FREEDMAN MS
CHRISIE S
NELSON R
RABINOVITCH H
FREEDMAN C
HARTUNG HP
RIECKMANN P
ARCHELOS J
JUNG S
WEILBACH F
FLACHENECKE P
SAUER J
HOMMES O
JONGEN P
BROUWER S
MCLEOD J
POLLARD J
NG R
SANDBERGWOLLHEIM M
KALLEN K
NILSSON P
EKBERG R
LUNDGREN A
JADBACK G
WIKSTROM J
MULTANEN J
VALJAKKA M
CARTON H
LISSOIR F
DECLERQ I
VIEREN M
PEETERS E
DUBOIS B
DEKEERSMAEKER E
VANHERLE A
HUGHES RAC
SHARRACK B
SOUDAIN S
PANELIUS M
ERALINNA J
SOILUHANNINEN M
MURTO S
MEDAER R
BROECKX J
VANROOSE E
BOGAERS A
BLUMHARDT LD
EDWARDS S
LIU C
ORPE V
BARNES D
SCHWARTZ M
STOY N
HARRAGHY C
BERTELSMANN F
UITDEHAAG B
NASSERI K
CHOFFLON M
ROTH S
KAPPOS L
HUBER S
BELLAICHE Y
SENN C
KING J
JUBERT J
WHITTEN S
NEWSOMDAVIS JM
PALACE J
LEE M
EVANGELOU N
PINTO A
CAVEY A
SINDIC CJM
MONTEYNE P
VEROUGSTRAETE D
VANDOORN PA
MOLL W
VISSER L
WILLEMS M
MARTINA I
BULJEVAC D
LOMAN L
BATES D
PANDIT D
IRVING J
RHODES B
RIDDEHOUGH A
ZHAO GJ
WANG X
CHENG Y
AMMOURY N
DUPONT F
GALAZKA A
HYDE R
OLSON M
PERNIN MO
ABDULAHAD AK
HOMMES O
NOSEWORTHY J
BORDEN E
OBRIEN P
WOLINSKY J
Citation: Gc. Ebers et al., RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF INTERFERON BETA-1A IN RELAPSING REMITTING MULTIPLE-SCLEROSIS/, Lancet, 352(9139), 1998, pp. 1498-1504
Citation: Ba. Kallmann et al., HUMAN CEREBRAL ENDOTHELIAL-CELLS ARE A MAJOR SOURCE OF SOLUBLE CELLULAR ADHESION MOLECULES DURING INFLAMMATORY CONDITIONS, Neurology, 50(4), 1998, pp. 2081-2081
Authors:
BLODORN B
BRUCK W
RIECKMANN P
FELGENHAUER K
MADER M
Citation: B. Blodorn et al., A METHOD FOR PREVENTING ARTIFACTUAL BINDING OF CRNA PROBES TO NEURONSCAUSED BY IN-SITU HYBRIDIZATION, Analytical biochemistry, 255(1), 1998, pp. 95-100
Authors:
BITSCH A
DACOSTA C
BUNKOWSKI S
WEBER F
RIECKMANN P
BRUCK W
Citation: A. Bitsch et al., IDENTIFICATION OF MACROPHAGE POPULATIONS EXPRESSING TUMOR-NECROSIS-FACTOR-ALPHA MESSENGER-RNA IN ACUTE MULTIPLE-SCLEROSIS, Acta Neuropathologica, 95(4), 1998, pp. 373-377
Citation: P. Rieckmann et al., TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) AND INTERLEUKIN-6 (IL-6) IN B-LYMPHOCYTE FUNCTION, Methods, 11(1), 1997, pp. 128-132
Authors:
RIECKMANN P
ALTENHOFEN B
RIEGEL A
BAUDEWIG J
FELGENHAUER K
Citation: P. Rieckmann et al., SOLUBLE ADHESION MOLECULES (SVCAM-1 AND SICAM-1) IN CEREBROSPINAL-FLUID AND SERUM CORRELATE WITH MRI ACTIVITY IN MULTIPLE-SCLEROSIS, Annals of neurology, 41(3), 1997, pp. 326-333
Citation: Hp. Hartung et P. Rieckmann, PATHOGENESIS OF IMMUNE-MEDIATED DEMYELINATION IN THE CNS, Journal of neural transmission. Supplementum, (50), 1997, pp. 173-181
Citation: N. Kruse et al., QUANTIFICATION OF CYTOKINE MESSENGER-RNA EXPRESSION BY RT PCR IN SAMPLES OF PREVIOUSLY FROZEN-BLOOD, Journal of immunological methods, 210(2), 1997, pp. 195-203
Authors:
ZYSK G
BRUCK W
FISCHER FR
MADER M
RIECKMANN P
NAU R
Citation: G. Zysk et al., LIMITED EFFICACY OF PENTOXIFYLLINE AS ANTIINFLAMMATORY AGENT IN EXPERIMENTAL PNEUMOCOCCAL MENINGITIS, Clinical and experimental immunology, 107(3), 1997, pp. 458-461
Authors:
KITZE B
HERZOG S
RIECKMANN P
POSER S
RICHT J
Citation: B. Kitze et al., NO EVIDENCE OF BORNA-DISEASE VIRUS-SPECIFIC ANTIBODIES IN MULTIPLE-SCLEROSIS PATIENTS IN GERMANY, Journal of neurology, 243(9), 1996, pp. 660-662
Authors:
REIMERS CD
ZIEMANN U
SCHEEL A
RIECKMANN P
KUNKEL M
KURTH C
Citation: Cd. Reimers et al., FASCICULATIONS - CLINICAL, ELECTROMYOGRAPHIC, AND ULTRASONOGRAPHIC ASSESSMENT, Journal of neurology, 243(8), 1996, pp. 579-584
Authors:
BRAUN N
MICHEL U
ERNST BP
METZNER R
BITSCH A
WEBER F
RIECKMANN P
Citation: N. Braun et al., GENE POLYMORPHISM AT POSITION -308 OF THE TUMOR-NECROSIS-FACTOR-ALPHA(TNF-ALPHA) IN MULTIPLE-SCLEROSIS AND ITS INFLUENCE ON THE REGULATIONOF TNF-ALPHA PRODUCTION, Neuroscience letters, 215(2), 1996, pp. 75-78
Authors:
RIECKMANN P
WEBER F
GUNTHER A
MARTIN S
BITSCH A
BROOCKS A
KITZE B
WEBER T
BORNER T
POSER S
Citation: P. Rieckmann et al., PENTOXIFYLLINE, A PHOSPHODIESTERASE INHIBITOR, INDUCES IMMUNE DEVIATION IN PATIENTS WITH MULTIPLE-SCLEROSIS, Journal of neuroimmunology, 64(2), 1996, pp. 193-200
Citation: P. Rieckmann et al., THE PHOSPHODIESTERASE INHIBITOR PENTOXIFYLLINE REDUCES EARLY SIDE-EFFECTS OF INTERFERON-BETA-1B TREATMENT IN PATIENTS WITH MULTIPLE-SCLEROSIS, Neurology, 47(2), 1996, pp. 604-604
Citation: P. Rieckmann et al., PENTOXIFYLLINE SYNERGIZES WITH INTERFERON-BETA AND REDUCES ITS SIDE-EFFECTS IN PATIENTS WITH MULTIPLE-SCLEROSIS, Neurology, 46(2), 1996, pp. 1072-1072
Authors:
MICHEL U
SCHNEIDER O
KIRCHHOF C
MEISEL S
SMIRNOV A
WILTFANG J
RIECKMANN P
Citation: U. Michel et al., PRODUCTION OF FOLLISTATIN IN PORCINE ENDOTHELIAL-CELLS - DIFFERENTIALREGULATION BY BACTERIAL COMPOUNDS AND THE SYNTHETIC GLUCOCORTICOID RU-28362, Endocrinology, 137(11), 1996, pp. 4925-4934